Philip Morris International Inc. is an international tobacco company. The Company's product portfolio primarily consists of cigarettes and smoke-free products, which include heat-not-burn, vapor, and oral nicotine products. The Company’s segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia, and PMI Duty Free Region (EA, AU & PMI DF); Americas Region; Swedish Match, and Wellness and Healthcare (W&H), which includes the operating of Vectura Fertin Pharma business.
The Company's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, and ZYN. The Company’s IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its smoke-free platform (Platform 1) uses a precisely controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 3.9M |
| Three Month Average Volume | 102.4M |
| High Low | |
| Fifty-Two Week High | 117.13414 EUR |
| Fifty-Two Week Low | 82.7672 EUR |
| Fifty-Two Week High Date | 30 Aug 2024 |
| Fifty-Two Week Low Date | 27 Oct 2023 |
| Price and Volume | |
| Current Price | 116.98233 EUR |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -0.95% |
| Thirteen Week Relative Price Change | 13.63% |
| Twenty-Six Week Relative Price Change | 24.82% |
| Fifty-Two Week Relative Price Change | 2.43% |
| Year-to-Date Relative Price Change | 10.66% |
| Price Change | |
| One Day Price Change | 0.60% |
| Thirteen Week Price Change | 21.61% |
| Twenty-Six Week Price Change | 37.25% |
| Five Day Price Change | 2.61% |
| Fifty-Two Week Price Change | 28.35% |
| Year-to-Date Price Change | 31.05% |
| Month-to-Date Price Change | 7.06% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | -6.8607 EUR |
| Book Value Per Share (Most Recent Quarter) | -5.94658 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | -23.14484 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | -23.63864 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 8.90608 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 21.53919 EUR |
| Revenue Per Share (Trailing Twelve Months) | 22.24781 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 4.84857 EUR |
| Dividend Per Share (Trailing Twelve Months) | 4.9055 EUR |
| Dividend Per Share (5 Year) | 4.60756 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 4.76008 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | 5.35901 EUR |
| Normalized (Last Fiscal Year) | 5.36898 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 4.76314 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 5.36413 EUR |
| Including Extraordinary Items (Last Fiscal Year) | 4.76008 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | 5.35901 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 1.87027 EUR |
| Cash Per Share (Most Recent Quarter) | 2.93362 EUR |
| Cash Flow Per Share (Last Fiscal Year) | 5.83967 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | 5.9262 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | 1.25556 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 6 |
| Cash Flow Revenue (Trailing Twelve Months) | 6 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 31.66% |
| Pretax Margin (Last Fiscal Year) | 29.64% |
| Pretax Margin (5 Year) | 35.14% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 63.52% |
| Gross Margin (Trailing Twelve Months) | 63.92% |
| Gross Margin (5 Year) | 65.46% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 32.78% |
| Operating Margin (Trailing Twelve Months) | 34.97% |
| Operating Margin (5 Year) | 37.58% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 23.01% |
| Net Profit Margin (Trailing Twelve Months) | 24.09% |
| Net Profit Margin (5 Year) | 27.54% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 5.59% |
| Revenue Growth (3 Year) | 3.54% |
| Revenue Change (Trailing Twelve Months) | 9.62% |
| Revenue Per Share Growth | 3.57% |
| Revenue Growth (5 Year) | 7.10% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -1.66% |
| Total Debt (5 Year) | 8.57% |
| Dividends | |
| Dividend Growth (3 Year) | 2.75% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 53.19% |
| EPS Change (Trailing Twelve Months) | 9.26% |
| EPS Growth (3 Year) | -0.32% |
| EPS Growth (5 Year) | -0.92% |
| EBITDA | |
| EBITDA (5 Year) | 2.93% |
| EBITDA (5 Year Interim) | 3.07% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -3.76% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 93 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 44.3B |
| Net Debt (Last Fiscal Year) | 44.8B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 5 |
| Price to Sales (Trailing Twelve Months) | 5 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 22 |
| PE Normalized (Last Fiscal Year) | 22 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 18 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 19 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 15 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 22 |
| Dividends | |
| Dividend Yield (5 Year) | 5.30% |
| Dividend Yield | 4.22% |
| Current Dividend Yield | 4.19% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | -100,000 |
| Price to Book (Most Recent Quarter) | -100,000 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | -100,000 |
| Long Term Debt to Equity (Most Recent Quarter) | -100,000 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 102.84% |
| Payout Ratio (Trailing Twelve Months) | 92.43% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 0 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 873 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 1.4K |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -81,000,000 |
| Free Cash Flow (Trailing Twelve Months) | 2.1B |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 12 |
| Net Interest Coverage (Trailing Twelve Months) | 12 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | -100,000 |
| Total Debt to Equity (Most Recent Quarter) | -100,000 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 12.77% |
| Return on Assets (Trailing Twelve Months) | 13.75% |
| Return on Assets (5 Year) | 17.77% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -99,999.99% |
| Return on Equity (Trailing Twelve Months) | -99,999.99% |
| Return on Equity (5 Year) | -99,999.99% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 23.56% |
| Return on Investment (Trailing Twelve Months) | 22.38% |
| Return on Investment (5 Year) | 34.25% |